Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)
94.60
+4.60 (5.11%)
Mar 14, 2025, 2:44 PM CST
SHA:688050 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
Net Income | - | 303.98 | 232.69 | 171.34 | 96.56 | Upgrade
|
Depreciation & Amortization | - | 75.49 | 43.35 | 32.04 | 26.67 | Upgrade
|
Other Amortization | - | 10.96 | 9.08 | 7.33 | 3.59 | Upgrade
|
Loss (Gain) From Sale of Assets | - | -0.11 | -0.01 | -0.02 | 0.15 | Upgrade
|
Loss (Gain) From Sale of Investments | - | -11.7 | -18.58 | -19.59 | -5.11 | Upgrade
|
Provision & Write-off of Bad Debts | - | 9.11 | 8.37 | 5.74 | 2.03 | Upgrade
|
Other Operating Activities | - | -9.62 | -3.07 | -1.91 | -0.39 | Upgrade
|
Change in Accounts Receivable | - | -103.52 | -45.76 | 1.12 | 18.11 | Upgrade
|
Change in Inventory | - | -85.12 | -22.82 | 3.35 | 1.67 | Upgrade
|
Change in Accounts Payable | - | 21.46 | 21.41 | 15.07 | -20.09 | Upgrade
|
Change in Other Net Operating Assets | - | 12.39 | 17.56 | 13.25 | - | Upgrade
|
Operating Cash Flow | - | 212.62 | 250.13 | 219.3 | 123.35 | Upgrade
|
Operating Cash Flow Growth | - | -15.00% | 14.06% | 77.78% | 144.30% | Upgrade
|
Capital Expenditures | - | -370.34 | -271.03 | -311.22 | -118.73 | Upgrade
|
Sale of Property, Plant & Equipment | - | 0.43 | 0.04 | - | 0.03 | Upgrade
|
Cash Acquisitions | - | -47.03 | - | - | - | Upgrade
|
Investment in Securities | - | 439.64 | -51.29 | -120.9 | -474.98 | Upgrade
|
Other Investing Activities | - | 15.97 | 21.44 | 19.75 | 5.97 | Upgrade
|
Investing Cash Flow | - | 32.67 | -307.84 | -420.37 | -587.71 | Upgrade
|
Long-Term Debt Issued | - | 12.16 | 10 | 143.37 | - | Upgrade
|
Long-Term Debt Repaid | - | -19.43 | -5.4 | - | -0.44 | Upgrade
|
Net Debt Issued (Repaid) | - | -7.27 | 4.6 | 143.37 | -0.44 | Upgrade
|
Issuance of Common Stock | - | 13.48 | 1.56 | 24.91 | 823.29 | Upgrade
|
Common Dividends Paid | - | -61.37 | -44.44 | -30.52 | - | Upgrade
|
Other Financing Activities | - | -8.41 | -26.79 | -0.02 | -18.12 | Upgrade
|
Financing Cash Flow | - | -63.57 | -65.07 | 137.74 | 804.73 | Upgrade
|
Foreign Exchange Rate Adjustments | - | 0.04 | -0.04 | -0.64 | 0.15 | Upgrade
|
Net Cash Flow | - | 181.76 | -122.82 | -63.97 | 340.51 | Upgrade
|
Free Cash Flow | - | -157.72 | -20.9 | -91.92 | 4.62 | Upgrade
|
Free Cash Flow Margin | - | -16.58% | -3.61% | -21.23% | 1.69% | Upgrade
|
Free Cash Flow Per Share | - | -0.83 | -0.11 | -0.49 | 0.03 | Upgrade
|
Cash Interest Paid | - | - | - | - | 0.01 | Upgrade
|
Cash Income Tax Paid | - | 157.93 | 58.75 | 57.3 | 36.58 | Upgrade
|
Levered Free Cash Flow | - | -215.88 | -110.16 | -105.6 | 5.29 | Upgrade
|
Unlevered Free Cash Flow | - | -209.74 | -108.89 | -105.14 | 5.29 | Upgrade
|
Change in Net Working Capital | - | 129.54 | 50.78 | -56.01 | -33.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.